Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis

Laboratory Investigation

Volumn 76, Issue 5, 1997, Pages 717-728

  Ståhle Bäckdahl, Mona ^a   Sandstedt, Bengt ^a   Bruce, Kerstin ^a   Lindahl, Anders ^b   Jiménez, Maria G ^c   Vega, José A ^c   López Otín, Carlos ^c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSIDAD DE OVIEDO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE;

ARTICLE; BONE REMODELING; CARTILAGE DEGENERATION; FETUS DEVELOPMENT; HUMAN; HUMAN CELL; OSSIFICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS;

AGED; ARTHRITIS, RHEUMATOID; BONE REMODELING; CHILD; CHILD, PRESCHOOL; COLLAGENASES; EMBRYONIC AND FETAL DEVELOPMENT; FEMALE; FOLLOW-UP STUDIES; GELATINASES; HUMANS; INFANT; MATRIX METALLOPROTEINASE 13; MATRIX METALLOPROTEINASE 2; METALLOENDOPEPTIDASES; MIDDLE AGED; OSTEOGENESIS; RNA, MESSENGER; SYNOVIAL FLUID;

EID: 0039167208     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Alexander CM and Werb Z (1991). Extracellular matrix degradation. In: Hay ED, editor: Cell biology of extracellular matrix. New York: Plenum Press, 255-302.
2. Balbín M, Fueyo A, López JM, Diaz-Itza I, Velasco G, and López-Otín C (1996). Expression of collagenase-3 in the rat ovary during the ovulatory process. J Endocrin 149:405-415.
3. Basset P, Bellocq JP, Wolf C, Stoll I, Limacher JM, Podjahcer OL, Chenard MP, Rio MC, and Chambon P (1990). A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature 348:699-704.
4. Birkedal-Hansen H (1995). Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735.
5. Canete-Soler R, Gui Y-H, Linask KK, and Muschel RJ (1995). Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos. Develop Dynam 204:30-40.
6. Ducy P and Karsenty G (1995). Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858-1869.
7. Erlebacher A, Filvaroff EH, Gitelman SE, and Derynck R (1995). Toward a molecular understanding of skeletal development. Cell 80:371-378.
8. Fosang AJ, Last K, Knäuper V, Murphy G, and Neame PJ (1996). Degradation of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 380:7-20.
9. Freije JMP, Díaz-Itza I, Balbín M, Sánchez LM, Blasco R, Tolivia J, and López-Otín C (1994). Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 269:16766-16773.
10. Gack S, Vallon R, Schaper J, Rüther U, and Angel P (1994). Phenotypic alterations in fos-transgenic mice correlate with changes in Fos/Jun dependent collagenase type I expression: Regulation of mouse metalloproteinases by carcinogens, tumor promoters, cAMP, and Fos oncoprotein. J Biol Chem 269:10363-10369.
11. Gack S, Vallon R, Schmidt J, Grigoriadis A, Tuckerman J, Schenkel J, Wiehar H, Wagner EF, and Angel P (1995). Expression of interstitial collagenase during skeletal development of the mouse is restricted to osteoblast-like cells and hypertrophic chondrocytes. Cell Growth Differ 6:759-767.
12. Karelina TV, Goldberg GI, and Eisen AZ (1995). Matrix metalloproteinases in blood vessel development in human fetal skin and cutaneous tumors. J Invest Dermatol 105:411-417.
13. Kinoh H, Sato H, Tsunezuka Y, Takino T, Kawashima A, Okada Y, and Seiki M (1996). MT-MMP, the cell surface activator of proMMP-2 (progelatinase A), is expressed with its substrate in mouse tissue during embryogenesis. J Cell Sci 109:953-959.
14. Knäuper V, López-Otín C, Smith B, Knight G, and Murphy G (1996a). Biochemical characterization of human collagenase-3. J Biol Chem 271:1544-1550.
15. Knäuper V, Will H, López-Otín C, Smith B, Atkinson SJ, Stanton H, Hembry RH, and Murphy G (1996b). Cellular mechanisms for human procollagenase-3 (MMP-13) activation. J Biol Chem 271:17124-17131.
16. Lefebvre O, Régnier C, Chenard M-P, Wendling C, Chambon P, Basset P, Rio M-C (1995). Developmental expression of mouse stromelysin-3 mRNA. Development 121:947-955.
17. Matrisian LM (1990). The matrix-degrading metalloproteinases. Bioessays 14:455-463.
18. Mattot V, Raes MB, Henriet P, Eeckhout Y, Stehelin D, Vandenbunder B, and Desbiens X (1995). Expression of interstitial collagenase is restricted to skeletal tissue during mouse embryogenesis. J Cell Sci 108:529-535.
19. McGowan KA, Bauer EA, and Smith LT (1994). Localization of type I human skin collagenase in developing embryonic and fetal skin. J Invest Dermatol 2:951-957.
20. Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, Geoghegan KF, and Hambor JE (1996). Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 7:761-768.
21. Pendás AM, Balbín M, Llano E, Jiménez MG, and Lopéz-Otín C (1996). Structural analysis and promoter characterization of the human collagenase -3 gene (MMP13). Genomics 40:222-233.
22. Pulford KAF, Rigney EM, Micklem KJ, Jones M, Stross WP, Gatter KC, and Mason DY (1989). KP1: A new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol 42:414-421.
23. Reboul P, Pelletier J-P, Tardif G, Cloutier J-M, and Martel-Pelletier J (1996). The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. J Clin Invest 97:2011-2019.
24. Reponen P, Sahlberg C, Huhtala P, Hurskainen T, Thesleff I, and Tryggvason K (1992). Molecular cloning of murine 72 kDa type IV collagenase and its expression during mouse development. J Biol Chem 267:7856-7862.
25. Reponen PC, Sahlberg C, Munaut C, Thesleff I, and Tryggvason K (1994). High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J Cell Biol 124:1091-1102.
26. Rodan GA and Noda M (1991). Genetic expression in osteoblastic cells. Crit Rev Eukaryot Gene Expr 1:85-98.
27. Rüther U, Komitowski D, Schubert FR, and Wagner EF (1989). C-fos expression induces bone tumors in transgenic mice. Oncogene 4:861-865.
28. Sandberg M and Vuori E (1987). Localization of types I, II, and III collagen mRNAs in developing human skeletal tissues by in situ hybridization. J Cell Biol 104:1077-1084.
29. Ståhle-Bäckdahl M, Sudbeck BD, Eisen AZ, Welgus HG, and Parks WC (1992). Expression of 92 kDa type IV collagenase in eosinophils associated with basal cell carcinoma. J Invest Dermatol 99:497-503.
30. Stetler-Stevenson WG, Aznavoorian S, and Liotta LA (1993). Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 9:541-573.
31. Wang ZQ, Grigoriadis AE, Möhle-Steinlein U, and Wagner EF (1991). A novel target cell for c-fos-induced oncogenesis: Development of chondrogenic tumours in embryonic stem cell chimeras. EMBO J 10:2437-2450.
32. Wang ZQ, Ovitt C, Grigoriadis A-E, Möhle-Steinlein U, Rüther U, and Wagner EF (1992). Bone and hematopoietic defects in mice lacking c-fos. Nature 360:741-745.
33. Wernicke D, Seyfert C, Hinzmann B, and Gromnica-Ihle E (1996). Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Rheumatol 23:590-595.
34. Wilson CL, Heppner KJ, Rudolph LA, and Matrisian LM (1995). The metalloproteinase matrilysin is preferentially expressed by epithelial cells in a tissue-restricted pattern in the mouse. Mol Biol Cell 6:851-869.